BiotechBrandon

MITC Readying for a Recovery?

Long
NASDAQ:MITC   None
Its been a brutal year for Nasdaq, and $MITC is no exception. Its been tracking downwards since December after the Black Friday dip in major US indexes. While $MITC has underperformed $NDX, its smaller enterprise value makes this equity more vulnerable to background volatility, and the fact that the MITC and NDX price action's have followed the same course indicates a tight nexus. That said, we may be in for a reversal soon, and the fact that $MITC's RSI is in undervalued territory speaks to this. MACD is also moving in a positive direction, so I for one am banking on the fact that once NASDAQ reestablishes its foot, $MITC will be right up there with it.

Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.